antoinette

Antoinette, Behavioral Health Director
Dacona, CO

antoinette

Antoinette,
Behavioral Health Program Director

In 2021, over 80,000 people in Colorado said they needed substance use treatment but did not get it: 77% of those people said they didn’t seek treatment because of stigma (feeling shame and judgment).

One study showed that healthcare providers who held stigmatizing attitudes and behaviors resulted in patients with an opioid use disorder (OUD) delaying seeking treatment by five to six years. Receiving discriminatory care and internalizing stigma delay treatment and perpetuate an individual’s ongoing use for years. People who delay treatment are at risk for additional harm due to their substance use, including overdose and death.

Dr. Nora Volkow, the Director of the National Institute on Drug Abuse (NIDA) at the National Institutes of Health, states, “Stigma on the part of healthcare providers who tacitly see a patient’s drug or alcohol problem as their own fault leads to substandard care or even to rejecting individuals seeking treatment. People with addiction internalize this stigma, feeling shame and refusing to seek treatment as a result.”

Additionally, Dr. Sarah Wakeman, Medical Director for the Massachusetts General Hospital Substance Use Disorder Initiative and Assistant Professor of Medicine at Harvard Medical School, has argued that stigma in the medical community and the criminal justice system as the biggest barrier to fighting the opioid epidemic, underscoring the incredible importance of removing it in interactions with individuals with an SUD.

Your support and compassion can make a huge difference in someone’s substance use journey, no matter where they are in readiness for change. Within the healthcare field, in particular, patient-centered care empowers patients with information that helps them make better treatment decisions and reduce preventable harm from active substance use. Additional Resources: Those in health care can fight against stigma through the Reducing Stigma Education Tools (ReSET) program here. Learn how to implement evidence-based strategies.

FDA-approved prescription medications such as buprenorphine, methadone, and naltrexone are used to treat opioid use disorders (OUD). These medications are safe to use for months, years, or even a lifetime, depending on the needs of each individual, and it has been proven that the longer they are taken, the less likely an individual is to overdose.

The science demonstrating the effectiveness of medication for OUD is strong. For example, methadone, extended-release injectable naltrexone (XR-NTX), and buprenorphine were each found to be more effective in reducing illicit opioid use than no medication in randomized clinical trials.

However, only about 19 percent of adults with opioid use disorder received medication for treatment in 2019, according to the National Survey on Drug Use and Health.

“What’s wonderful about where we are in the treatment of OUD, is that we have medications that work and are safe. But we underutilize them. Medications are the gold standard.”

Dr. Lesley Brooks
Greeley, CO

medications-dr

medications-dr

Fentanyl is a synthetic opioid 50 times more potent than heroin. Although fentanyl is an FDA-approved pain medication, the current opioid overdose crisis is being driven by illicitly manufactured fentanyl. Fentanyl potency is extremely unpredictable—its effects are felt quickly and do not last very long (about 30–60 minutes).

Law enforcement agencies can greatly benefit from requiring officers to carry naloxone and training them to administer it. Officers are often the first on the scene and are uniquely positioned to save someone’s life. Officers have also reported that the requirement to carry and administer naloxone improves the public perception of law enforcement within a community.

What You Can Do 

Criminal justice professionals can act as advocates for policy change. They can also educate themselves on treatment programs and options to recommend when interacting with people struggling with an SUD. Adopting a non-judgmental tone and approach when interacting with people with an SUD goes a long way. Law enforcement professionals can carry naloxone and encourage fellow officers to do so, and become educated on local treatment resources.

Further Reading on Incarceration and MOUD

Read more about jail-based medications for opioid use disorder in the National Sheriff’s Association and National Commission on Correctional Health Care’s guide and the Jail Based Behavioral Health Services (JBBS) Program in Colorado.

Behavioral Health Professionals: Medications to Treat Opioid Use Disorder (MOUD) and Counseling

Medication to treat OUD should be integrated with outpatient and residential treatment. Some patients may benefit from different levels of care at different points in their lives, such as outpatient counseling, intensive outpatient treatment, inpatient treatment, or long-term therapeutic communities. Patients treated in these settings should have access to medications to treat OUD.

Under federal law 42.CFR 8.12, patients receiving treatment in Opioid Treatment Programs (OTPs) must receive counseling, which may include different forms of behavioral therapy.

These services are required along with medical, vocational, educational, and other assessment and treatment services. Regardless of how medications are provided, it is more effective when counseling and other behavioral health therapies are included to provide patients with a whole-person approach.